PBYIPuma Biotechnology, Inc.

$305M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$142M

Net Income

-$142M

EPS (Diluted)

$-4.73

Cash Flow

Operating Cash Flow

-$77M

Free Cash Flow

-$78M

Stock-Based Comp.

$39M

Balance Sheet

Total Assets

$163M

Total Liabilities

$46M

Stockholders' Equity

$117M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$142M	-$55M	-159.5%
Net Income	-$142M	-$55M	-159.8%

PBYI FY 2014 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena